For help on how to get the results you want, see our search tips.
593 results
Categories
Human Remove Human filter
Medicine
Orphan designations Remove Orphan designations filter
Withdrawn applications Remove Withdrawn applications filter
Orphan designation status
Withdrawn Remove Withdrawn filter
-
List item
Orphan designation: Allogeneic anti-Epstein Barr virus cytotoxic T lymphocytes expanded ex vivo for: Treatment of post-transplant lymphoproliferative disorder (updated)
Date of designation: 21/07/2021, Withdrawn, Last updated: 21/07/2021 -
List item
Orphan designation: 2-Methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-phenol (fosbretabulin tromethamine) for: Treatment of anaplastic thyroid cancer (updated)
Date of designation: 21/07/2021, Withdrawn, Last updated: 21/07/2021 -
List item
Orphan designation: Recombinant human aspartylglucosaminidase for: Treatment of aspartylglucosaminuria
Date of designation: 15/01/2015, Withdrawn, Last updated: 25/06/2021 -
List item
Orphan designation: Chimeric group B adenovirus (11p/3) with deletions in the E3 and E4 regions (enadenotucirev) for: Treatment of ovarian cancer
Date of designation: 12/02/2015, Withdrawn, Last updated: 25/06/2021 -
List item
Orphan designation: Adeno-associated viral vector serotype 2/2 containing a gene encoding the channelrhodopsin-2 protein for: Treatment of retinitis pigmentosa
Date of designation: 14/10/2016, Withdrawn, Last updated: 11/06/2021 -
List item
Orphan designation: Adeno-associated viral vector expressing lipoprotein lipase (alipogene tiparvovec) for: Treatment of lipoprotein-lipase deficiency
Date of designation: 09/03/2004, Withdrawn, Last updated: 31/05/2021 -
List item
Orphan designation: Recombinant human alpha-1-microglobulin for: Treatment of pre-eclampsia
Date of designation: 04/07/2014, Withdrawn, Last updated: 11/05/2021 -
List item
Orphan designation: tripotassium citrate monohydrate, Potassium hydrogen carbonate for: Treatment of distal renal tubular acidosis
Date of designation: 20/06/2017, Withdrawn, Last updated: 03/05/2021 -
List item
Orphan designation: Codon-optimised human ornithine transcarbamylase mRNA complexed with lipid-based nanoparticles for: Treatment of ornithine transcarbamylase deficiency
Date of designation: 27/06/2018, Withdrawn, Last updated: 28/04/2021 -
List item
Orphan designation: Ixazomib for: Treatment of systemic light chain amyloidosis
Date of designation: 08/11/2012, Withdrawn, Last updated: 09/04/2021 -
List item
Orphan designation: 2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)-piperazin-1-yl)-8-methylimidazo[1,2-alpha]pyridin-3-yl)-(methyl)amino)-4-(4-fluorophenyl)-thiazole-5-carbonitrile (ziritaxestat) for: Treatment of idiopathic pulmonary fibrosis
Date of designation: 29/08/2016, Withdrawn, Last updated: 09/04/2021 -
List item
Orphan designation: Chimeric monoclonal antibody against claudin 6 for: Treatment of ovarian cancer
Date of designation: 24/01/2013, Withdrawn, Last updated: 08/04/2021 -
List item
Orphan designation: Recombinant human glutamate oxaloacetate transaminase 1 for: Treatment of glioma
Date of designation: 12/02/2015, Withdrawn, Last updated: 07/04/2021 -
List item
Orphan designation: romilkimab for: Treatment of systemic sclerosis
Date of designation: 09/01/2020, Withdrawn, Last updated: 06/04/2021 -
List item
Orphan designation: ziritaxestat for: Treatment of systemic sclerosis
Date of designation: 09/01/2020, Withdrawn, Last updated: 06/04/2021 -
List item
Orphan designation: Terguride for: Treatment of systemic sclerosis
Date of designation: 24/01/2013, Withdrawn, Last updated: 22/03/2021 -
List item
Orphan designation: milciclib maleate for: Treatment of malignant thymoma
Date of designation: 08/11/2012, Withdrawn, Last updated: 22/03/2021 -
List item
Orphan designation: Allogeneic umbilical cord blood CD34+ cells cultured ex vivo with Notch ligand Delta1 (dilanubicel) for: Treatment in haematopoietic stem cell transplantation
Date of designation: 17/01/2018, Withdrawn, Last updated: 22/03/2021 -
List item
Orphan designation: Levosimendan for: Treatment of amyotrophic lateral sclerosis
Date of designation: 22/02/2018, Withdrawn, Last updated: 19/03/2021 -
List item
Orphan designation: Humanised single-chain monoclonal antibody against CD37 (otlertuzumab) for: Treatment chronic lymphocytic leukaemia
Date of designation: 06/12/2012, Withdrawn, Last updated: 19/03/2021 -
List item
Orphan designation: Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene (volrubigene ralaparvovec) for: Treatment of Crigler-Najjar syndrome
Date of designation: 22/08/2014, Withdrawn, Last updated: 19/03/2021 -
List item
Orphan designation: Nimorazole maleate for: Treatment of squamous-cell carcinoma of the head and neck in patients undergoing radiotherapy
Date of designation: 09/02/2012, Withdrawn, Last updated: 19/03/2021 -
List item
Orphan designation: Three chimeric human/murine monoclonal antibodies against the Ebola (Zaire) surface glycoprotein (porgaviximab) for: Treatment for Ebola virus disease
Date of designation: 09/10/2015, Withdrawn, Last updated: 19/03/2021 -
List item
Orphan designation: 5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole (ezutromid) for: Treatment of Duchenne muscular dystrophy
Date of designation: 04/12/2008, Withdrawn, Last updated: 10/02/2021 -
List item
Orphan designation: Human monoclonal antibody against Pseudomonas aeruginosa IATS-O1 for: Treatment of pneumonia caused by serotype O1 Pseudomonas aeruginosa
Date of designation: 28/01/2010, Withdrawn, Last updated: 03/02/2021